Fresenius Medical…
USUSDFresenius Medical Care AG & Co. KGaA (US:FMCQF) — Misc Health and Biotechnology Services. Antal børser, hvor selskabets aktier handles: 5. På denne side — kurs og diagram, udbytte, største aktionærer og historik over antal aktier.
Om Virksomheden
- Websted
- fmcna.com
- Sektor
- Health Care · Misc Health and Biotechnology Services
- Hovedkontor
- BAD HOMBURG, Germany
- Administrerende Direktør
- Helen Giza
- Ansatte
- 125 364
- Grundlagt
- 1975
- Udestående Aktier
- 266.11 mio. pr. 2025-12-31
- Free Float
- 198.56 mio.
- Markedsværdi
- 11.86 mia. USD
- Insidere
- 25.02%
- Institutionelle Investorer
- 52.82%
- Branche (SIC)
- Services-Misc Health & Allied Services, NEC
- Juridisk Form
- 6QQB
- ISIN
- DE0005785802
- LEI
- 549300CP8NY40UP89Q40
- Udbetalingsgrad
- 42.7%
- FCF
- 1.78 mia. EUR
- Udbetaling / FCF
- 22%
- Gæld
- 11.0 mia. EUR3.5 år FCF
- Udbyttestreak
- 28 år
- Indtjening, FCF og udbetalt udbytte — for de 12 måneder frem til 30.06.2026 (selskabets seneste rapport).
Beskrivelse
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Børser og Tickere
| Børs | Ticker | Valuta | Pris | Type |
|---|---|---|---|---|
| US USA Stocks | FMCQF OTC | USD | 43.8204 +7.38% | almindelige aktier |
| LSE London Stock Exchange | 0H9X IOB | EUR | 44.12 +0.00% | almindelige aktier |
| MI Borsa Italiana (Milan) | 1FME sekundær | EUR | 39.5 +0.69% | almindelige aktier |
| VI Vienna Stock Exchange | FME sekundær | EUR | 40.31 +0.12% | almindelige aktier |
| XETRA Xetra | FME primær | EUR | 39.8 -1.68% | almindelige aktier |
Udbytte
Fresenius Medical Care AG & Co. KGaA (FMCQF) udbetaler udbytte én gang om året. Pr. År (12 måneder op til og med den senest annoncerede betaling): 1.49 EUR pr. Aktie (betalinger: 1). Baseret på betalingshistorikken forventes næste ex-udbyttedato omkring 24.05.2027. Uafbrudt udbyttehistorik: 28 år.
| Ex-Dato | Udbetaling | Beløb | % | Type | Ticker |
|---|---|---|---|---|---|
| 2026-05-22 | 2026-05-27 | 1.4900 EUR | 4.0/4.0 % | årlig | US:FMCQF |
| 2025-05-23 | 2025-05-27 | 1.4400 EUR | 2.8/2.8 % | årlig | US:FMCQF |
| 2024-05-17 | 2024-05-22 | 1.1900 EUR | 2.9/2.9 % | årlig | US:FMCQF |
Største Ejere
| Ejer | Andel | Aktier | Rapportdato |
|---|---|---|---|
| Dodge & Cox Funds-Dodge… | 5.61% | 13.75 mio. | 2026-06-30 |
| Artisan Partners Funds I… | 2.68% | 6.58 mio. | 2026-06-30 |
| VANGUARD STAR FUNDS-Vang… | 1.25% | 3.07 mio. | 2026-07-31 |
| Dodge & Cox Funds-Dodge… | 1.06% | 2.61 mio. | 2026-06-30 |
| VANGUARD TAX-MANAGED FUN… | 0.8% | 1.95 mio. | 2026-06-30 |
| iShares Trust-iShares Co… | 0.59% | 1.44 mio. | 2026-08-31 |
| Columbia Funds Series Tr… | 0.57% | 1.4 mio. | 2026-05-31 |
| Bridge Builder Trust-Bri… | 0.55% | 1.35 mio. | 2026-06-30 |
| SEI INSTITUTIONAL INVEST… | 0.52% | 1.27 mio. | 2026-07-31 |
| Datum One Series Trust-B… | 0.44% | 1.08 mio. | 2026-06-30 |
| Pacer Advisors, Inc. | 0.16% | 387 540 | 2026-06-30 |
| Generali Investments Cee… | 0% | 9 100 | 2026-06-30 |
| Paradigm Asset Managemen… | 0% | 697 | 2026-06-30 |
